Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease.

[1]  Martin H. Teicher,et al.  S(+)apomorphines selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat , 1985, Neuropharmacology.

[2]  P. N. Kaul,et al.  Biological disposition of apomorphine. IV. Isolation and characterization of "bound" apomorphine. , 1961, Journal of pharmaceutical sciences.

[3]  B. Eriksson,et al.  Determination of apomorphine in plasma and brain tissue by ion-pair extraction and liquid chromatography. , 1979, Journal of chromatography.

[4]  J. P. Long,et al.  Centrally acting emetics. 5. Preparation and pharmacology of 10-hydroxy-11 methoxyaporphine (isoapocodeine). In vitro enzymatic methylation of apomorphine. , 1972, Journal of medicinal chemistry.

[5]  B. Westerink,et al.  Do neuroleptics prevent the penetration of dopamine agonists into the brain? , 1979, European journal of pharmacology.

[6]  D. Humphrey,et al.  High-performance liquid chromatographic separation of apomorphine and its O-methyl metabolites. , 1979, Journal of chromatography.

[7]  J. Leysen,et al.  Apomorphine: chemistry, pharmacology, biochemistry. , 1976, International review of neurobiology.

[8]  A J Lees,et al.  Dopamine agonists in Parkinson's disease: a look at apomorphine , 1993, Fundamental & clinical pharmacology.

[9]  J. Nutt,et al.  Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance , 1995, Movement disorders : official journal of the Movement Disorder Society.

[10]  K. Davis,et al.  Rapid Determination of Apomorphine in Brain and Plasma Using High-Performance Liquid Chromatography , 1984 .